Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beate Ritz

Showing results (411-420 of 433) with videos related to

Pageof 44
Sort By:
Journal of Occupational Medicine and Toxicology (London, England)|February 15, 2018
Diagnosis, monitoring and prevention of exposure-related non-communicable diseases in the living and working environment: DiMoPEx-project is designed to determine the impacts of environmental exposure on human healthLygia Therese Budnik, Balazs Adam, Maria Albin, et al.
Plos Genetics|November 21, 2014
Lack of replication of the GRIN2A-by-coffee interaction in Parkinson diseaseIsmaïl Ahmed, Pei-Chen Lee, Christina M Lill, et al.
The European Respiratory Journal|January 13, 2017
A joint ERS/ATS policy statement: what constitutes an adverse health effect of air pollution? An analytical frameworkGeorge D Thurston, Howard Kipen, Isabella Annesi-Maesano, et al.
Basic & Clinical Pharmacology & Toxicology|January 30, 2008
The faroes statement: human health effects of developmental exposure to chemicals in our environmentPhilippe Grandjean, David Bellinger, Ake Bergman, et al.
Acta Neuropathologica|May 15, 2021
α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophySuman Dutta, Simon Hornung, Adira Kruayatidee, et al.
Acta Neuropathologica|May 24, 2021
Correction to: α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophySuman Dutta, Simon Hornung, Adira Kruayatidee, et al.
Neurobiology of Aging|May 21, 2017
Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's diseaseIgnacio F Mata, Catherine O Johnson, James B Leverenz, et al.
Environmental Health Perspectives|August 13, 2013
Research on the premotor symptoms of Parkinson's disease: clinical and etiological implicationsHonglei Chen, Edward A Burton, G Webster Ross, et al.
Plos Genetics|August 31, 2011
Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffeeTaye H Hamza, Honglei Chen, Erin M Hill-Burns, et al.
JAMA Neurology|September 3, 2014
APOE, MAPT, and SNCA genes and cognitive performance in Parkinson diseaseIgnacio F Mata, James B Leverenz, Daniel Weintraub, et al.
Pageof 44

Showing results (411-420 of 433) with videos related to

Sort By:
Pageof 44
Journal of Occupational Medicine and Toxicology (London, England)|February 15, 2018
Diagnosis, monitoring and prevention of exposure-related non-communicable diseases in the living and working environment: DiMoPEx-project is designed to determine the impacts of environmental exposure on human healthLygia Therese Budnik, Balazs Adam, Maria Albin, et al.
Plos Genetics|November 21, 2014
Lack of replication of the GRIN2A-by-coffee interaction in Parkinson diseaseIsmaïl Ahmed, Pei-Chen Lee, Christina M Lill, et al.
The European Respiratory Journal|January 13, 2017
A joint ERS/ATS policy statement: what constitutes an adverse health effect of air pollution? An analytical frameworkGeorge D Thurston, Howard Kipen, Isabella Annesi-Maesano, et al.
Basic & Clinical Pharmacology & Toxicology|January 30, 2008
The faroes statement: human health effects of developmental exposure to chemicals in our environmentPhilippe Grandjean, David Bellinger, Ake Bergman, et al.
Acta Neuropathologica|May 15, 2021
α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophySuman Dutta, Simon Hornung, Adira Kruayatidee, et al.
Acta Neuropathologica|May 24, 2021
Correction to: α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophySuman Dutta, Simon Hornung, Adira Kruayatidee, et al.
Neurobiology of Aging|May 21, 2017
Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's diseaseIgnacio F Mata, Catherine O Johnson, James B Leverenz, et al.
Environmental Health Perspectives|August 13, 2013
Research on the premotor symptoms of Parkinson's disease: clinical and etiological implicationsHonglei Chen, Edward A Burton, G Webster Ross, et al.
Plos Genetics|August 31, 2011
Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffeeTaye H Hamza, Honglei Chen, Erin M Hill-Burns, et al.
JAMA Neurology|September 3, 2014
APOE, MAPT, and SNCA genes and cognitive performance in Parkinson diseaseIgnacio F Mata, James B Leverenz, Daniel Weintraub, et al.
Pageof 44